Holen Sie sich die Stockscreener-App
108.80
0.29%
0.31
Handel nachbörslich:
108.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$108.49
Offen:
$106.43
24-Stunden-Volumen:
1.55M
Relative Volume:
1.07
Marktkapitalisierung:
$12.34B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
46.30
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
-6.79%
1M Leistung:
+11.67%
6M Leistung:
+19.76%
1J Leistung:
-14.22%
1-Tages-Spanne:
$106.37
$108.85
1-Wochen-Bereich:
$106.37
$118.21
52-Wochen-Spanne:
$81.36
$128.04
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Vergleichen Sie RVTY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
108.80 | 12.30B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
578.61 | 222.48B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
218.89 | 155.25B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
670.46 | 54.04B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
230.15 | 40.13B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.85 | 37.78B | 6.95B | 1.30B | 1.15B | 4.5696 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
Revvity Q4 2025 Earnings Forecast: Revenue & EPS Estimates Ahead of ReportNews and Statistics - IndexBox
Revvity (RVTY) Q4 Earnings: What To Expect - Finviz
A Look at Revvity's Upcoming Earnings Report - Benzinga
Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? - sharewise.com
Revvity (RVTY) Valuation Check After Recent Share Price Rebound And Margins Reset Narrative - Yahoo Finance
Revvity Inc (RVTY) Stock Price Down 3.4% on Jan 29 - GuruFocus
Revvity trades higher on earnings guidance above consensus - MSN
Is Revvity Inc. impacted by rising ratesJuly 2025 Update & Consistent Profit Trade Alerts - mfd.ru
Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Revvity Inc. to Issue Quarterly Dividend of $0.07 (NYSE:RVTY) - MarketBeat
Revvity declares quarterly dividend of $0.07 per share By Investing.com - Investing.com Nigeria
Revvity Keeps Quarterly Dividend at $0.07 a Share, Payable May 8 to Holders of Record April 17 - marketscreener.com
Revvity declares quarterly dividend of $0.07 per share - Investing.com
Revvity Inc declares quarterly dividend of $0.07 per share - marketscreener.com
Revvity declares $0.07 dividend - MSN
Revvity Board Declares Quarterly Dividend - Yahoo Finance Singapore
Revvity (RVTY) Earnings Expected to Grow: Should You Buy? - Finviz
Pharma News: Is Revvity Inc impacted by rising ratesEarnings Recap Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Sells 24,911 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Recap Report: Whats the beta of Revvity Inc stockPrice Action & Smart Allocation Stock Reports - baoquankhu1.vn
Will Revvity (RVTY) beat estimates again in its next earnings report? - MSN
Revvity Inc. (NYSE:RVTY) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Here's why you should retain Revvity stock in your portfolio for now - MSN
Revvity expects to report Q4 revenue of $772 million - MSN
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report? - yourwyominglink.com
AI-augmented platform for molecular and materials discovery - Labmate Online
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - The Globe and Mail
Trend Recap: Is CNFRZ affected by consumer sentimentWeekly Stock Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
Massachusetts Financial Services Co. MA Has $100.43 Million Stock Position in Revvity Inc. $RVTY - MarketBeat
A scientist's guide to electronic laboratory notebook selection - Drug Discovery News
Campbell & CO Investment Adviser LLC Purchases New Holdings in Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Shares Decline Amid Market Fluctuations - GuruFocus
Zacks Research Has Negative Estimate for Revvity Q2 Earnings - MarketBeat
Earnings Miss: Is Revvity Inc a play on infrastructure spendingJuly 2025 Rallies & Risk Controlled Stock Alerts - baoquankhu1.vn
Revvity’s Quiet Rally: Is This Under-the-Radar Lab-Tech Stock about to Break Out? - AD HOC NEWS
What to expect from Revvity’s Q4 2025 earnings report - MSN
Sumitomo Mitsui Trust Group Inc. Trims Stake in Revvity Inc. $RVTY - MarketBeat
Highs Report: Is Revvity Inc a good ESG investmentJuly 2025 Snapshot & Verified Swing Trading Watchlist - baoquankhu1.vn
Surprises Report: Can Revvity Inc outperform in the next rallyJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook - Sahm
The Bull Case For Revvity (RVTY) Could Change Following Upbeat 2025 Guidance And New Lilly AI Alliance - Yahoo Finance
What's Going On With Revvity Stock Wednesday?Revvity (NYSE:RVTY) - Benzinga
Weekly Trades: Is Revvity Inc showing insider buyingPortfolio Update Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Revvity stock surges on exceeding profit forecasts - MSN
How (RVTY) Movements Inform Risk Allocation Models - Stock Traders Daily
Revvity (NYSE:RVTY) Shares Gap UpHere's Why - MarketBeat
Revvity Inc expects existing end market trends to continue into 2026presentation - marketscreener.com
Risk Hedge: What dividend safety score for Revvity Inc stock2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Revvity Raises 2025 Outlook With Strong Preliminary Results - TipRanks
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):